Logo image of 1PFE.MI

PFIZER INC (1PFE.MI) Stock Fundamental Analysis

BIT:1PFE - Borsa Italiana Milan - US7170811035 - Common Stock - Currency: EUR

25.59  -0.11 (-0.41%)

Fundamental Rating

4

1PFE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 52 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of 1PFE while its profitability can be described as average. 1PFE is cheap, but on the other hand it scores bad on growth. Finally 1PFE also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year 1PFE was profitable.
In the past year 1PFE had a positive cash flow from operations.
1PFE had positive earnings in each of the past 5 years.
In the past 5 years 1PFE always reported a positive cash flow from operatings.
1PFE.MI Yearly Net Income VS EBIT VS OCF VS FCF1PFE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B

1.2 Ratios

1PFE has a Return On Assets of 1.94%. This is comparable to the rest of the industry: 1PFE outperforms 41.67% of its industry peers.
Looking at the Return On Equity, with a value of 4.61%, 1PFE is in line with its industry, outperforming 43.75% of the companies in the same industry.
1PFE has a Return On Invested Capital of 5.41%. This is comparable to the rest of the industry: 1PFE outperforms 47.92% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1PFE is in line with the industry average of 12.45%.
The last Return On Invested Capital (5.41%) for 1PFE is well below the 3 year average (13.15%), which needs to be investigated, but indicates that 1PFE had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.94%
ROE 4.61%
ROIC 5.41%
ROA(3y)9.65%
ROA(5y)8.92%
ROE(3y)21.22%
ROE(5y)20.78%
ROIC(3y)13.15%
ROIC(5y)10.02%
1PFE.MI Yearly ROA, ROE, ROIC1PFE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

1PFE has a Profit Margin (7.07%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of 1PFE has declined.
Looking at the Operating Margin, with a value of 21.87%, 1PFE is in the better half of the industry, outperforming 64.58% of the companies in the same industry.
In the last couple of years the Operating Margin of 1PFE has grown nicely.
With a Gross Margin value of 70.82%, 1PFE perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
1PFE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 21.87%
PM (TTM) 7.07%
GM 70.82%
OM growth 3Y-2.8%
OM growth 5Y1.5%
PM growth 3Y-45.18%
PM growth 5Y-33.24%
GM growth 3Y-4.47%
GM growth 5Y-2.32%
1PFE.MI Yearly Profit, Operating, Gross Margins1PFE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60 80

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1PFE is creating some value.
1PFE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1PFE has less shares outstanding
Compared to 1 year ago, 1PFE has a worse debt to assets ratio.
1PFE.MI Yearly Shares Outstanding1PFE.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B
1PFE.MI Yearly Total Debt VS Total Assets1PFE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50B 100B 150B 200B

2.2 Solvency

1PFE has an Altman-Z score of 1.95. This is not the best score and indicates that 1PFE is in the grey zone with still only limited risk for bankruptcy at the moment.
1PFE's Altman-Z score of 1.95 is in line compared to the rest of the industry. 1PFE outperforms 43.75% of its industry peers.
The Debt to FCF ratio of 1PFE is 8.23, which is on the high side as it means it would take 1PFE, 8.23 years of fcf income to pay off all of its debts.
1PFE has a Debt to FCF ratio of 8.23. This is comparable to the rest of the industry: 1PFE outperforms 45.83% of its industry peers.
A Debt/Equity ratio of 0.69 indicates that 1PFE is somewhat dependend on debt financing.
1PFE's Debt to Equity ratio of 0.69 is in line compared to the rest of the industry. 1PFE outperforms 43.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 8.23
Altman-Z 1.95
ROIC/WACC0.61
WACC8.85%
1PFE.MI Yearly LT Debt VS Equity VS FCF1PFE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 20B 40B 60B 80B

2.3 Liquidity

1PFE has a Current Ratio of 1.00. This is a normal value and indicates that 1PFE is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.00, 1PFE is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
A Quick Ratio of 0.73 indicates that 1PFE may have some problems paying its short term obligations.
With a Quick ratio value of 0.73, 1PFE is not doing good in the industry: 85.42% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 0.73
1PFE.MI Yearly Current Assets VS Current Liabilites1PFE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B 50B

3

3. Growth

3.1 Past

The earnings per share for 1PFE have decreased strongly by -10.10% in the last year.
Measured over the past years, 1PFE shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.41% on average per year.
1PFE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.90%.
Measured over the past years, 1PFE shows a small growth in Revenue. The Revenue has been growing by 7.46% on average per year.
EPS 1Y (TTM)-10.1%
EPS 3Y-12.38%
EPS 5Y-9.41%
EPS Q2Q%723.53%
Revenue 1Y (TTM)-12.9%
Revenue growth 3Y11.99%
Revenue growth 5Y7.46%
Sales Q2Q%33.78%

3.2 Future

Based on estimates for the next years, 1PFE will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.45% on average per year.
1PFE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.36% yearly.
EPS Next Y61.14%
EPS Next 2Y27.49%
EPS Next 3Y18.8%
EPS Next 5Y9.45%
Revenue Next Year7.2%
Revenue Next 2Y3.59%
Revenue Next 3Y2.52%
Revenue Next 5Y0.36%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1PFE.MI Yearly Revenue VS Estimates1PFE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B 100B
1PFE.MI Yearly EPS VS Estimates1PFE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.24, the valuation of 1PFE can be described as reasonable.
Based on the Price/Earnings ratio, 1PFE is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of 1PFE to the average of the S&P500 Index (28.47), we can say 1PFE is valued rather cheaply.
1PFE is valuated reasonably with a Price/Forward Earnings ratio of 8.89.
Based on the Price/Forward Earnings ratio, 1PFE is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of 1PFE to the average of the S&P500 Index (92.74), we can say 1PFE is valued rather cheaply.
Industry RankSector Rank
PE 10.24
Fwd PE 8.89
1PFE.MI Price Earnings VS Forward Price Earnings1PFE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1PFE is valued a bit cheaper than 77.08% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1PFE indicates a somewhat cheap valuation: 1PFE is cheaper than 68.75% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.22
EV/EBITDA 9.62
1PFE.MI Per share data1PFE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

1PFE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1PFE's earnings are expected to grow with 18.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.17
PEG (5Y)N/A
EPS Next 2Y27.49%
EPS Next 3Y18.8%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.39%, 1PFE is a good candidate for dividend investing.
1PFE's Dividend Yield is rather good when compared to the industry average which is at 2.69. 1PFE pays more dividend than 100.00% of the companies in the same industry.
1PFE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 6.39%

5.2 History

The dividend of 1PFE has a limited annual growth rate of 3.78%.
Dividend Growth(5Y)3.78%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

222.18% of the earnings are spent on dividend by 1PFE. This is not a sustainable payout ratio.
1PFE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP222.18%
EPS Next 2Y27.49%
EPS Next 3Y18.8%
1PFE.MI Yearly Income VS Free CF VS Dividend1PFE.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B
1PFE.MI Dividend Payout.1PFE.MI Dividend Payout, showing the Payout Ratio.1PFE.MI Dividend Payout.PayoutRetained Earnings

PFIZER INC

BIT:1PFE (2/3/2025, 7:00:00 PM)

25.59

-0.11 (-0.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-29 2024-10-29/bmo
Earnings (Next)02-04 2025-02-04/bmo
Inst Owners67.53%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap145.02B
Analysts72
Price Target30.39 (18.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.39%
Yearly Dividend1.64
Dividend Growth(5Y)3.78%
DP222.18%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.99%
Min EPS beat(2)30.28%
Max EPS beat(2)69.69%
EPS beat(4)4
Avg EPS beat(4)75.1%
Min EPS beat(4)30.28%
Max EPS beat(4)145.39%
EPS beat(8)8
Avg EPS beat(8)49.93%
EPS beat(12)12
Avg EPS beat(12)39.63%
EPS beat(16)15
Avg EPS beat(16)32%
Revenue beat(2)2
Avg Revenue beat(2)9.37%
Min Revenue beat(2)1.51%
Max Revenue beat(2)17.22%
Revenue beat(4)3
Avg Revenue beat(4)5.44%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)17.22%
Revenue beat(8)4
Avg Revenue beat(8)3.04%
Revenue beat(12)7
Avg Revenue beat(12)3.42%
Revenue beat(16)9
Avg Revenue beat(16)3.19%
PT rev (1m)-1.37%
PT rev (3m)-2.36%
EPS NQ rev (1m)-5.73%
EPS NQ rev (3m)-20.27%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)3.57%
Revenue NQ rev (1m)-0.52%
Revenue NQ rev (3m)-1.84%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)1.14%
Valuation
Industry RankSector Rank
PE 10.24
Fwd PE 8.89
P/S 2.49
P/FCF 18.22
P/OCF 13.31
P/B 1.62
P/tB N/A
EV/EBITDA 9.62
EPS(TTM)2.5
EY9.77%
EPS(NY)2.88
Fwd EY11.25%
FCF(TTM)1.4
FCFY5.49%
OCF(TTM)1.92
OCFY7.51%
SpS10.26
BVpS15.76
TBVpS-6.19
PEG (NY)0.17
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.94%
ROE 4.61%
ROCE 7.46%
ROIC 5.41%
ROICexc 5.72%
ROICexgc 22.55%
OM 21.87%
PM (TTM) 7.07%
GM 70.82%
FCFM 13.68%
ROA(3y)9.65%
ROA(5y)8.92%
ROE(3y)21.22%
ROE(5y)20.78%
ROIC(3y)13.15%
ROIC(5y)10.02%
ROICexc(3y)15.8%
ROICexc(5y)11.8%
ROICexgc(3y)54.59%
ROICexgc(5y)39.27%
ROCE(3y)17.69%
ROCE(5y)13.61%
ROICexcg growth 3Y6.45%
ROICexcg growth 5Y-2.08%
ROICexc growth 3Y-4.71%
ROICexc growth 5Y0%
OM growth 3Y-2.8%
OM growth 5Y1.5%
PM growth 3Y-45.18%
PM growth 5Y-33.24%
GM growth 3Y-4.47%
GM growth 5Y-2.32%
F-Score5
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 8.23
Debt/EBITDA 3.19
Cap/Depr 44.05%
Cap/Sales 5.05%
Interest Coverage 4.54
Cash Conversion 56.21%
Profit Quality 193.46%
Current Ratio 1
Quick Ratio 0.73
Altman-Z 1.95
F-Score5
WACC8.85%
ROIC/WACC0.61
Cap/Depr(3y)59.41%
Cap/Depr(5y)55.97%
Cap/Sales(3y)4.41%
Cap/Sales(5y)5.25%
Profit Quality(3y)148.35%
Profit Quality(5y)126.65%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.1%
EPS 3Y-12.38%
EPS 5Y-9.41%
EPS Q2Q%723.53%
EPS Next Y61.14%
EPS Next 2Y27.49%
EPS Next 3Y18.8%
EPS Next 5Y9.45%
Revenue 1Y (TTM)-12.9%
Revenue growth 3Y11.99%
Revenue growth 5Y7.46%
Sales Q2Q%33.78%
Revenue Next Year7.2%
Revenue Next 2Y3.59%
Revenue Next 3Y2.52%
Revenue Next 5Y0.36%
EBIT growth 1Y-34.77%
EBIT growth 3Y8.85%
EBIT growth 5Y9.07%
EBIT Next Year205.1%
EBIT Next 3Y46.45%
EBIT Next 5Y27.43%
FCF growth 1Y-64.8%
FCF growth 3Y-25.54%
FCF growth 5Y-18.86%
OCF growth 1Y-57.66%
OCF growth 3Y-15.47%
OCF growth 5Y-11.28%